drugset / Trial / NCT04958382

Study for Evaluating the Efficacy of Ciprofol in Patients Under Narcotic Sleep With Chronic Insomnia

NCT04958382

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single center, randomized, single blind, exploratory clinical study.About 30 patients with chronic insomnia are planned to be enrolled in this study and randomized into two groups by a ratio of 4:1 (Figure 1), with group 1 (24 subjects) for ciprofol and group 2 (6 subjects) for placebo (fat emulsion). Cognitive behavioral therapy (CBT) will be given to these patients during the treatment.

Timeline

Start
2021-12-01
Primary completion
2023-12-31
Completion
2024-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.4 mg/kg Intravenous
Subject Cipepofol Small molecule 1.6 mg/kg Intravenous

Indications